Preclinical evaluation of anti-CD38 therapy in mature T-cell neoplasms

Blood Adv. 2023 Jul 25;7(14):3637-3641. doi: 10.1182/bloodadvances.2023009807.
No abstract available

MeSH terms

  • ADP-ribosyl Cyclase 1
  • Humans
  • Neoplasms*
  • T-Lymphocytes*

Substances

  • ADP-ribosyl Cyclase 1